← Back to all trials
Recruiting
NCT07857044
Left-atrial Fibrosis in Persistent Atrial Fibrillation and Its Comorbidities
Conditions: Atrial Fibrillation, Sleep Apnea, Primary Aldosteronism
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 200
Sponsor: Christina Berr. MD
Location: University hospital Augsburg Augsburg Bavaria
Summary
Pulmonary vein isolation is an established intervention for atrial fibrillation. Patients with a paroxysmal atrial fibrillation have no or only few comorbidities and a good prognosis in respect to their atrial fibrillation. In contrast, patients with persistent atrial fibrillation often suffer from relevant comorbidities and recurrence of atrial fibrillation is common. Left-atrial fibrosis and its electrophysiological consequences are involved in the recurrence rate, but pathophysiological mechanisms are yet to be better characterized. The study investigates relevant comorbidities to elucidated their effect on atrial fibrosis and recurrence rates of atrial fibrillation. Furthermore, the investigators evaluate the prevalence of these comorbidities.
Eligibility Criteria
Inclusion Criteria:
* persistent atrial fibrillation, eligible for ablation
* BMI 19-40
Exclusion Criteria:
* valvular atrial fibrillation
* formerly ablation
* medication interfereing with measurements of atrial fibrosis
* known or treated comorbidities (OSAS, PA)
Source: ClinicalTrials.gov (NCT07857044). StuddyBuddy aggregates publicly available trial information.